Today, the END Fund announces its Audacious project – the Deworming Innovation Fund – in four strategic countries: Ethiopia, Kenya, Rwanda, and Zimbabwe.

In April 2019, The Audacious Project announced its support of the END Fund and seven other organizations. The Audacious Project is a collaborative funding initiative between TED and leading nonprofits that convenes funders and social entrepreneurs in order to scale solutions to the world’s most urgent challenges. By facilitating initial funding for the Deworming Innovation Fund, The Audacious Project has helped to catalyze additional commitments.

Neglected tropical diseases (NTDs) are a group of parasitic and bacterial infectious diseases affecting more than 1.7 billion of the world’s population, with about 40% of this burden concentrated in Africa. Two of the most common NTDs are intestinal worms and schistosomiasis, both of which are parasitic worm infections. Treatments for these diseases, commonly known as deworming, reduce stunted growth in children and improve food and vitamin absorption. Studies have shown that children who are dewormed are 25% more likely to attend school, and adults are able to increase their earnings by 20%. Moreover, deworming also improves labor productivity and long-term economic gains.

Slated to run through 2025, the Deworming Innovation Fund aims to accelerate progress towards tackling parasitic worm infections that affect more than 40 million children in Ethiopia, Rwanda, Zimbabwe, and Kenya. The END Fund will leverage drug donations from key pharmaceutical companies and coordinate with governments and partners to create robust delivery systems. Over the next five years, people at risk of intestinal worms and schistosomiasis in these four strategic countries will benefit from life-changing deworming treatment. Thus, ensuring that nobody is left behind and that at-risk demographics often overlooked in treatment campaigns, like women of reproductive age and children who are not yet in school, are reached.

“With initial funding raised through The Audacious Project, the END Fund garnered additional support for the Deworming Innovation Fund, which enables us to accelerate progress even faster than we had envisioned,” said CEO Ellen Agler. “This groundbreaking capital allows us to reduce the burden of intestinal worms and schistosomiasis in the four countries, and invest in innovative approaches to treatment, prevention, and sustainability,” said Agler.

Since 2012, the END Fund has been working to end NTDs in Kenya and has distributed more than 17 million treatments. Most recently, the END Fund has been collaborating with the Ministry of Health to implement the Breaking Transmission Strategy, a national five-year plan to control and eliminate neglected tropical diseases. In 2018 alone, Kenya completed its fifth round of deworming for school-age children, piloted a new drug therapy for lymphatic filariasis (LF) that accelerated the end of the disease, and provided surgeries for men with debilitating conditions caused by advanced LF.

The generous and unwavering level of support to end NTDs continues to provide an opportunity to scale up proven approaches, trial new innovative approaches, and foster increased levels of community partnership. Through the Deworming Innovation Fund, the quality of life for millions can be improved because of the significant improvement to mental, physical, and social health. The END Fund is proud to stand with other global change-makers on this World NTD Day to ensure that these diseases get the necessary attention and investment that they deserve.

Anchor funding for this initiative has been committed through a collaboration of Audacious Project partners including The ELMA Foundation, Delta Philanthropies, Sir Christopher Hohn (administered via the Children’s Investment Fund Foundation), Rosamund Zander and Hansjörg Wyss for the Wyss Medical Foundation, and Virgin Unite.

Distributed by African Media Agency (AMA) on behalf of End Fund.

ABOUT the END Fund
The END Fund is the only private philanthropic initiative solely dedicated to ending the five most common neglected tropical diseases (NTDs), which affect more than 1.7 billion people globally. It efficiently puts private capital to work, advocating for NTD programs that are innovative, integrated, and cost-effective. It facilitates strong partnerships with the private sector and has supported national disease control programs in 30 countries.
Since its founding in 2012, with its partners, the END Fund has provided over 740 million donated treatments worth over $1 billion, over 12,900 surgeries for people suffering from the effects of the advanced stages of elephantiasis and trachoma, and trained more than 1.4 million people in NTD control and elimination efforts.

ABOUT THE AUDACIOUS PROJECT
Launched in April 2018, The Audacious Project is a collaborative funding initiative that’s catalyzing social impact on a grand scale. Housed at TED, the nonprofit devoted to ideas worth spreading, and with support from leading social impact advisor The Bridgespan Group, The Audacious Project convenes funders and social entrepreneurs with the goal of supporting bold solutions to the world’s most urgent challenges. The Audacious Project’s funding collective is made up of respected organizations and individuals in philanthropy, including the Skoll Foundation, Virgin Unite, The Valhalla Charitable Foundation, ELMA Philanthropies and more. Each year The Audacious Project supports a new cohort. The 2019 recipients are Center for Policing Equity, Educate Girls, Institute for Protein Design, Salk Institute for Biological Studies, The END Fund, The Nature Conservancy, Thorn and Waterford’s UPSTART project.